What is USP Brazil's cybersecurity risk score?

USP Brazil has an AI-generated cybersecurity risk score of 755 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has USP Brazil experienced?

According to Rankiteo, USP Brazil currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has USP Brazil been affected by any supply chain cyber incidents ?

According to Rankiteo, USP Brazil has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does USP Brazil have SOC 2 Type 1 certification ?

According to Rankiteo, USP Brazil is not certified under SOC 2 Type 1.

Does USP Brazil have SOC 2 Type 2 certification ?

According to Rankiteo, USP Brazil does not hold a SOC 2 Type 2 certification.

Does USP Brazil comply with GDPR ?

According to Rankiteo, USP Brazil is not listed as GDPR compliant.

Does USP Brazil have PCI DSS certification ?

According to Rankiteo, USP Brazil does not currently maintain PCI DSS compliance.

Does USP Brazil comply with HIPAA ?

According to Rankiteo, USP Brazil is not compliant with HIPAA regulations.

Does USP Brazil have ISO 27001 certification ?

According to Rankiteo,USP Brazil is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does USP Brazil operate in ?

USP Brazil operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does USP Brazil have ?

USP Brazil employs approximately None employees people worldwide.

Does USP Brazil own any subsidiaries ?

USP Brazil presently has no subsidiaries across any sectors.

How many LinkedIn followers does USP Brazil have ?

USP Brazil's official LinkedIn profile has approximately 7,159 followers.

What is the NAICS classification code for USP Brazil ?

USP Brazil is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does USP Brazil have a Crunchbase profile ?

No, USP Brazil does not have a profile on Crunchbase.

Does USP Brazil have a LinkedIn profile ?

Yes, USP Brazil maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/usp-brazil.

How many cybersecurity incidents has USP Brazil experienced ?

As of October 2, 2026, Rankiteo reports that USP Brazil has not experienced any cybersecurity incidents.

How many peer or competitor companies does USP Brazil have ?

USP Brazil has an estimated 5,771 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

USP Brazil

Boost Score +25 with badge (5 left)

755

/1000

Fair

780

/1000

Fair

USP Brazil Vendor Cyber Rating & Cyber Score

usp.org

Add Your Compliance Badge

USP-Brazil supports USP's mission to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. See Brazil’s USP Education initiatives at: https://www.uspbrasil.com.br/cursos/

USP Brazil

USP Brazil CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

USP Brazil Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for USP Brazil

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for USP Brazil in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for USP Brazil in 2026.

Incident Types USP Brazil vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for USP Brazil in 2026.

Incident History - USP Brazil (X = Date, Y = Severity)

Loading…

SUBSIDIARY

USP Brazil Subsidiaries

USP Brazil

Pharmaceutical Manufacturing

Website: https://latam-edu.usp.org/?utm_source=BRlinkedin&utm_medium=BRlinkedin&utm_campaign=BRLinkedIn-Button&utm_id=BRLinkedIn-Button

Company Size: 1,001-5,000 employees

US PharmacopeiaPharmaceutical Manufacturing

USP Science & ResearchPharmaceutical Manufacturing

USP IndiaPharmaceutical Manufacturing

USP Latin AmericaPharmaceutical Manufacturing

Food Chemicals Codex (FCC)Food Production

Loading…

USP Brazil Similar Companies

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Servier

servier.com

Servier is an independent international pharmaceutical group governed by a foundation. With its unique governance model, the Group is committed to therapeutic progress to serve patients and integrates the patient voice at every stage of the medicine life cycle. As a leading global player in cardiology and venous diseases, Servier aims to become a leading innovator in oncology and neurology. Through precision medicine, the Group intends to offer targeted therapeutic solutions for a limited number of rare diseases and invests nearly 20% of its brand-name sales in R&D. Headquartered in France, Servier relies on its more than 20,000 employees and a solid geographic presence with medicines distributed in more than 130 countries. In the 2024/25 financial year, the Group achieved revenues of €6.9 billion. -- To report a suspected adverse event with a Servier drug, please visit servier.com

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Loading…

NEWS

USP Brazil CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

November 18, 2025 08:00 AM

Cyberattacks on universities and scientific institutions on the rise in Brazil

The first warning came on the night of Friday, March 28, via a cybersecurity software application: a hacker attack was underway against the...

Read Article

February 17, 2025 08:00 AM

The Top 10 Best Colleges in Brazil for Tech Enthusiasts in 2025

In 2025, Brazil emerges as a tech education hub, with top universities like Universidade de São Paulo (USP) and Universidade Estadual de Campinas (UNICAMP)...

Read Article

January 15, 2025 08:00 AM

FAPESP aims to boost the development of quantum technologies in Brazil

Foundation launches program aimed at accelerating creation, training human resources and stimulating scientific and technological leadership...

Read Article

June 13, 2024 01:46 PM

EC-Council and Datec (Fiji) Pte Limited Collaborate to Boost Cybersecurity in the Pacific Region

EC-Council inventor of the world-famous Certified Ethical Hacker, and Datec (Fiji) Pte Limited, a prominent technology solutions provider, have announced a...

Read Article

August 22, 2023 07:00 AM

USAID Launches The Digital Connectivity and Cybersecurity Partnership

USAID aims to increase digital access and connectivity and improve efficient delivery and use of digital services throughout the Pacific region.

Read Article

July 06, 2023 12:37 AM

More barriers to prevent cyberattacks

Brazilian data security legislation takes important steps forward, but devices connected to the internet are still vulnerable.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-103761

SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a memory exhaustion vulnerability in TransferMetadata::receivePeerNotify that allows unauthenticated attackers to grow process memory without limit. Attackers can repeatedly send notify frames up to 1 MB to the handshake RPC port, filling the uncapped notifys vector until the out-of-memory killer terminates the engine.

Published

Date2026-10-01

Updated

Date2026-10-01

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-103760

SUMMARY

Mooncake transfer engine through 0.3.13.post1 contains a denial of service vulnerability that allows unauthenticated remote attackers to block the handshake daemon by never reading replies. Attackers can send a Metadata request to the handshake RPC port and stall SocketHandShakePlugin's single listener thread in writeFully(), breaking all subsequent handshakes, metadata fetches, notify and probe requests.

Published

Date2026-10-01

Updated

Date2026-10-01

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.2

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.2

REFERENCES

CVE-2025-71427

SUMMARY

Office-PowerPoint-MCP-Server through 2.0.7 contains a path traversal vulnerability that allows MCP callers to write and read files outside the working directory by supplying absolute paths or ../ sequences. Attackers can steer an AI agent via prompt injection to abuse save_presentation, open_presentation, or manage_image output_path to overwrite any server-writable file or load external files.

Published

Date2026-10-01

Updated

Date2026-10-01

RISK INFORMATION (Score: 6.8)

cvss3

Base Score: 6.8

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:N

cvss4

Base Score: 7.6

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

1.6

REFERENCES

CVE-2026-86344

SUMMARY

A flaw was found in 389-ds-base. An unauthenticated remote attacker can send a complete LDAP operation followed by the first bytes of an incomplete LDAPMessage on the same connection, causing the server to hand that connection to a second worker thread before the first worker's result is flushed. The second worker blocks until nsslapd-ioblocktimeout while holding the connection mutex, preventing delivery of the completed operation's result. Repeating this across a small number of connections proportional to the configured worker-thread pool size exhausts the entire pool under default configuration, denying service to all clients (anonymous and authenticated, plaintext and TLS) for as long as the attacker maintains the connections.

Published

Date2026-10-01

Updated

Date2026-10-01

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

3.9

REFERENCES

CVE-2026-71454

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in CWE-79 - Cross-site Scripting CAPEC-63 allows Cross-Site Scripting (XSS). This issue affects CAPEC-63: before 3.0b63.

Published

Date2026-10-01

Updated

Date2026-10-01

RISK INFORMATION (Score: )

cvss4

Base Score: 5.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://www.johnsoncontrols.com/trust-center/cybersecurity/security-advisories

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

USP Brazil Vendor Cyber Rating & Cyber Score

USP Brazil A.I CyberSecurity Scoring

USP Brazil CyberSecurity News & History

USP Brazil Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for USP Brazil

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types USP Brazil vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - USP Brazil (X = Date, Y = Severity)

USP Brazil Subsidiaries

USP Brazil

USP Brazil Similar Companies

Hikma Pharmaceuticals

Johnson & Johnson Innovative Medicine

Merck Group

MANKIND PHARMA LTD

Servier

SUN PHARMA

Parexel

Catalent

Sanofi

USP Brazil CyberSecurity News

Cyberattacks on universities and scientific institutions on the rise in Brazil

The Top 10 Best Colleges in Brazil for Tech Enthusiasts in 2025

FAPESP aims to boost the development of quantum technologies in Brazil

EC-Council and Datec (Fiji) Pte Limited Collaborate to Boost Cybersecurity in the Pacific Region

USAID Launches The Digital Connectivity and Cybersecurity Partnership

More barriers to prevent cyberattacks

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

USP Brazil CyberSecurity News & History

USP Brazil Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for USP Brazil

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types USP Brazil vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - USP Brazil (X = Date, Y = Severity)

USP Brazil Subsidiaries

USP Brazil

USP Brazil Similar Companies

Hikma Pharmaceuticals

Johnson & Johnson Innovative Medicine

Merck Group

MANKIND PHARMA LTD

Servier

SUN PHARMA

Parexel

Catalent

Sanofi

USP Brazil CyberSecurity News

Cyberattacks on universities and scientific institutions on the rise in Brazil

The Top 10 Best Colleges in Brazil for Tech Enthusiasts in 2025

FAPESP aims to boost the development of quantum technologies in Brazil

EC-Council and Datec (Fiji) Pte Limited Collaborate to Boost Cybersecurity in the Pacific Region

USAID Launches The Digital Connectivity and Cybersecurity Partnership

More barriers to prevent cyberattacks

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo